Chiron Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.66M Buy
+59,126
New +$1.57M 1.7% 12
2025
Q3
$1.85M Sell
72,684
-388
-0.5% -$9.58K 1.59% 16
2025
Q2
$1.77M Sell
73,072
-1,963
-3% -$45.8K 1.54% 16
2025
Q1
$1.9M Buy
75,035
+14,740
+24% +$386K 1.73% 10
2024
Q4
$1.6M Sell
60,295
-7,975
-12% -$216K 1.51% 11
2024
Q3
$1.98M Sell
68,270
-1,716
-2% -$50.1K 1.75% 9
2024
Q2
$1.96M Buy
69,986
+526
+0.8% +$14.5K 1.87% 8
2024
Q1
$1.93M Buy
69,460
+28,079
+68% +$779K 1.75% 5
2023
Q4
$1.19M Sell
41,381
-11,448
-22% -$346K 1.04% 24
2023
Q3
$1.75M Buy
52,829
+32,426
+159% +$1.15M 1.51% 10
2023
Q2
$748K Buy
20,403
+10,000
+96% +$389K 0.59% 39
2023
Q1
$424K Buy
10,403
+2,248
+28% +$97.1K 0.3% 69
2022
Q4
$418K Sell
8,155
-1,100
-12% -$52.7K 0.29% 65
2022
Q3
$405K Buy
9,255
+1,245
+16% +$60.5K 0.27% 73
2022
Q2
$420K Sell
8,010
-24,022
-75% -$1.22M 0.27% 74
2022
Q1
$1.66M Sell
32,032
-26,643
-45% -$1.38M 1.05% 13
2021
Q4
$3.46M Sell
58,675
-5,896
-9% -$292K 2.5% 4
2021
Q3
$2.78M Sell
64,571
-69,938
-52% -$3.1M 2.03% 5
2021
Q2
$5.27M Sell
134,509
-19,320
-13% -$751K 4.39% 3
2021
Q1
$5.57M Buy
153,829
+90,843
+144% +$3.23M 4.73% 3
2020
Q4
$2.32M Sell
62,986
-18,305
-23% -$671K 1.91% 7
2020
Q3
$2.83M Buy
+81,291
New +$2.85M 2.28% 5

Other funds holding PFE

Chiron Capital Management's PFE Position: Q1 2026 in Review

Chiron Capital Management opened a new position in Pfizer (PFE) in Q1 2026: 59,126 shares worth $1.66M. The stake represents 1.7% of the portfolio and ranks #12 among its holdings. This is a return to the name: Chiron Capital Management previously reported a position in PFE as recently as Q3 2025.

Chiron Capital Management first reported a position in PFE in Q3 2020 and has held it in 22 quarters since. The position peaked at $5.57M in Q1 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Chiron Capital Management held 59,126 shares of Pfizer worth $1.66M as of Q1 2026.
  • Pfizer was a new Chiron Capital Management position in Q1 2026.
  • Pfizer made up 1.7% of Chiron Capital Management's portfolio in Q1 2026, its #12 holding.
  • Chiron Capital Management first reported a position in Pfizer in Q3 2020 and has held it in 22 quarters since.
  • Chiron Capital Management's Pfizer position peaked at $5.57M in Q1 2021.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Chiron Capital Management's 13F filing for Q1 2026, filed 21 Apr 2026.